Evidence map›Paper›PMID 41517814›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2026

The Oral Microbiome in Amyotrophic Lateral Sclerosis Shows Differentially Abundant Organisms in Limb Versus Bulbar Onset Disease: A Binational Study.

Sarah M Jacob, Bugyeong Son, Sahar Bagheri, Sukyoung Lee, Jamie Leckie, Bhavneet Chohan, Cole Belway, James Mascarenhas, Theodore Mobach, Lawrence W Korngut and 5 more

Abstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sarah M JacobHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0001-5798-1194
Bugyeong SonCell Therapy Center, Department of Neurology, Hanyang University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0009-0004-5372-5248
Sahar BagheriInternational Microbiome Centre, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Sukyoung LeeHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-0586-445X
Jamie LeckieHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-3166-8973
Bhavneet ChohanHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Cole BelwayHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
James MascarenhasHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Theodore MobachDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lawrence W KorngutHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Keith A SharkeyHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0001-9560-1711
Jinseok ParkCell Therapy Center, Department of Neurology, Hanyang University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-6581-5831
Minh Dang NguyenHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-4547-8617
Seung Hyun KimCell Therapy Center, Department of Neurology, Hanyang University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-9644-9598
Gerald PfefferHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-7657-7098

Funding

ALS Canada Discovery GrantBarry Barrett FoundationCIHRFondation Brain CanadaInternational Development Research CouncilMinistry of Health and WelfareMinistry of Science and ICT, South Korea RS-2024-00348451Rose Family Foundation
6 · The paper itself

Abstract

background and purposeAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of upper and lower motor neurons leading to progressive disability and death. Approximately 10% of cases are caused by single-gene disorders with the remaining 90% of cases presumed to be caused by a combination of environmental and genetic factors. The microbiome (the ensemble of microorganisms that colonize body surfaces and organs) was recently identified for its importance in the pathogenesis of ALS.

methodsIn this study, we recruited 100 participants from two ethnically and geographically distinct sites (71 from Calgary, Canada, and 29 from Seoul, Republic of Korea) which included 59 ALS participants and 41 controls. All participants provided saliva samples for oral microbial analysis using 16S rRNA sequencing. Basic demographic information was collected from all participants, and ALS participants provided additional clinical information including site of disease onset, disease duration, and ALS Functional Rating Scale - Revised score.

resultsSignificant differences in beta diversity of the oral microbiomes were seen between limb- and bulbar-onset ALS participants. Two bacterial genera were differentially abundant between these groups, Bifidobacteriaceae

conclusionsDespite the cohort and household effects, our study identified differentially abundant organisms that may be important to the phenotypic variability of ALS and should be considered for future study. Our study provides novel insights into design for future multi-site microbiome research in ALS.

Indexed as

amyotrophic lateral sclerosisenvironmental healthmicrobiotaoral microbiomephenotype

Identifiers

PMID41517814
PMCPMC12802088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.